Emcure Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, Emcure Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of ₹1,914. The average 1-year stock price forecast is 6.01% higher than the current stock price, while the lowest is ₹1,640 (-9.14%) and the highest is ₹2,100 (+16.34%).

Price Target: ₹1,914 (+6.01%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	₹1,640	₹1,914	₹1,945	₹2,100
Change	-9.14%	+6.01%	+7.76%	+16.34%

Analyst Ratings

The average analyst rating for Emcure Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Apr '26	May '26	Jun '26
Strong Buy	5	5	5	5	4	4
Buy	0	0	0	0	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	6	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Alok Dalal Jefferies	Jefferies	Buy Maintains ₹1,970 → ₹2,100	Buy	Maintains	₹1,970 → ₹2,100	+16.34%	Jun 24, 2026

Financial Forecast

Revenue This Year

104.40B

from 92.04B

13.43%

from 92.04B

Revenue Next Year

117.03B

from 104.40B

12.10%

from 104.40B

EPS This Year

60.83

from 52.29

16.33%

from 52.29

EPS Next Year

74.70

from 60.83

22.80%

from 60.83

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	58.55B	59.86B	66.58B	78.96B	92.04B	104.40B
Revenue Growth	16.33%	2.23%	11.23%	18.59%	16.56%	13.43%
Gross Profit	35.69B	36.67B	41.23B	46.73B	55.46B	62.77B
Gross Margin	60.95%	61.27%	61.92%	59.19%	60.26%	60.13%
Operating Income	10.85B	9.21B	9.17B	10.85B	13.74B	16.58B
Net Income	6.62B	5.32B	4.98B	6.81B	9.24B	11.50B
EPS	-	-	-	-	52.29	60.83
EPS Growth	-	-	-	-	41.96%	16.33%
Forward PE	-	-	-	24.17	27.50	29.67
Dividend / Share	3.00	2.00	-	3.00	3.60	3.80
Dividend Growth	-	-33.33%	-	-	20.00%	5.47%
Free Cash Flow	2.30B	1.63B	3.67B	2.78B	3.11B	11.58B
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	104.9B
Avg	104.4B
Low	104.0B

Revenue Growth

Revenue Growth	2027	2028	2029
High	14.0%
Avg	13.4%
Low	13.0%

EPS Forecast

EPS	2027	2028	2029
High	61.80
Avg	60.83
Low	59.00

EPS Growth

EPS Growth	2027	2028	2029
High	18.2%
Avg	16.3%
Low	12.8%